Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$4.43M Buy
99,218
+2,256
+2% +$96.4K 0.62% 72
2018
Q2
$3.88M Sell
96,962
-479
-0.5% -$18.9K 0.56% 74
2018
Q1
$3.9M Sell
97,441
-2,744
-3% -$114K 0.43% 105
2017
Q4
$4.31M Buy
100,185
+3,369
+3% +$155K 0.47% 102
2017
Q3
$4.82M Buy
96,816
+842
+0.9% +$40.7K 0.58% 79
2017
Q2
$4.6M Buy
95,974
+2,573
+3% +$123K 0.59% 78
2017
Q1
$4.23M Buy
93,401
+30
+0% +$1.27K 0.59% 78
2016
Q4
$3.78M Sell
93,371
-26,707
-22% -$1.05M 0.57% 76
2016
Q3
$4.59M Sell
120,078
-3,411
-3% -$137K 0.73% 59
2016
Q2
$5.17M Buy
123,489
+1,255
+1% +$51.5K 0.85% 45
2016
Q1
$4.91M Sell
122,234
-1,778
-1% -$71.4K 0.8% 51
2015
Q4
$5.29M Sell
124,012
-9,104
-7% -$419K 0.82% 48
2015
Q3
$6.32M Buy
133,116
+926
+0.7% +$47.1K 0.96% 34
2015
Q2
$6.55M Buy
132,190
+107,582
+437% +$5.45M 0.87% 40
2015
Q1
$1.22M Buy
24,608
+2,214
+10% +$106K 0.16% 132
2014
Q4
$1.02M Buy
22,394
+1,729
+8% +$83.9K 0.13% 130
2014
Q3
$1.17M Buy
20,665
+321
+2% +$17.2K 0.15% 123
2014
Q2
$1.08M Buy
20,344
+264
+1% +$14K 0.14% 134
2014
Q1
$1.05M Buy
+20,080
New +$1.02M 0.14% 135

Other funds holding SNY

AFAM Capital's SNY Position: Q3 2018 in Review

AFAM Capital increased its Sanofi (SNY) stake by 2.3% in Q3 2018, buying an estimated $96.4K and bringing the position to 99,218 shares worth $4.43M. The position accounts for 0.62% of the portfolio, ranked #72.

AFAM Capital first reported a position in SNY in Q1 2014 and has held it in 19 quarters since. The position peaked at $6.55M in Q2 2015. 480 funds tracked by Wall St. Rank hold SNY as of Q3 2018.

  • AFAM Capital held 99,218 shares of Sanofi worth $4.43M as of Q3 2018.
  • AFAM Capital bought 2,256 Sanofi shares in Q3 2018, an estimated $96.4K.
  • Sanofi made up 0.62% of AFAM Capital's portfolio in Q3 2018, its #72 holding.
  • AFAM Capital first reported a position in Sanofi in Q1 2014 and has held it in 19 quarters since.
  • AFAM Capital's Sanofi position peaked at $6.55M in Q2 2015.
  • 480 funds tracked by Wall St. Rank held Sanofi as of Q3 2018.

Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.